Advisornet Financial’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-2
Closed -$313 – 2201
2024
Q1
$313 Buy
+2
New +$322 ﹤0.01% 1925
2022
Q4
– Sell
-2
Closed – – 2509
2022
Q3
$0 Sell
2
-8
-80% -$1.37K ﹤0.01% 2074
2022
Q2
$2K Sell
10
-3
-23% -$469 ﹤0.01% 1746
2022
Q1
$2K Buy
13
+4
+44% +$850 ﹤0.01% 1827
2021
Q4
$2K Hold
9
– – ﹤0.01% 1865
2021
Q3
$3K Buy
+9
New +$2.94K ﹤0.01% 1724
2020
Q2
– Sell
-180
Closed -$22K – 1951
2020
Q1
$22K Hold
180
– – ﹤0.01% 1051
2019
Q4
$30K Buy
+180
New +$29.9K ﹤0.01% 1063

Other funds holding ONC

Advisornet Financial's ONC Position: Q2 2024 in Review

Advisornet Financial sold out of BeOne Medicines Ltd (ONC) in Q2 2024, closing a stake of 2 shares — an estimated $313 sold.

Advisornet Financial first reported a position in ONC in Q4 2019 and held it in 8 quarters. The position peaked at $30K in Q4 2019. 200 funds tracked by Wall St. Rank hold ONC as of Q2 2024.

  • Advisornet Financial reported no remaining BeOne Medicines Ltd position as of Q2 2024 after selling out during the quarter.
  • Advisornet Financial sold 2 BeOne Medicines Ltd shares in Q2 2024, an estimated $313.
  • Advisornet Financial first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 8 quarters.
  • Advisornet Financial's BeOne Medicines Ltd position peaked at $30K in Q4 2019.
  • 200 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2024.

Based on Advisornet Financial's 13F filing for Q2 2024, filed 16 Jul 2024.